Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:2010:403076.
doi: 10.1155/2010/403076. Epub 2010 May 5.

Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum

Niina M Saarinen  1 , Annika I Smeds, José L Peñalvo, Tarja Nurmi, Herman Adlercreutz, Sari Mäkelä
Affiliations

Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum

Niina M Saarinen et al. J Nutr Metab. 2010.

Abstract

Enterolactone (EL) is an enterolignan found in human subjects. In this pilot study, the enantiomeric ratios of serum EL were determined in serum from healthy adults during consumption of habitual diet, and after an 8-day supplementation with flaxseed (25 g/day). (-)EL dominated in all serum samples collected during habitual diet consumption. However, the ratio of (-)EL and (+)EL enantiomers differed markedly between individuals. Flaxseed ingestion increased significantly the proportion of (+)EL in all subjects. Moreover, a small but significant increase in serum (-)EL concentration was measured. After flaxseed ingestion, (-)EL concentrations correlated with those of (+)EL suggesting that the stereochemistry of the parent plant lignan in flaxseed is not a major determinant of EL formation in human subjects. Comparison of EL concentrations obtained with the validated chromatographic methods (HPLC-MS/MS, HPLC-CEAD, and GC-MS) and the time-resolved fluoroimmunoassay (TR-FIA) revealed that the immunoassay method underestimates human serum EL concentrations after the flaxseed ingestion.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of enterolactone enantiomers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Heinonen S, Nurmi T, Liukkonen K, et al. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. Journal of Agricultural and Food Chemistry. 2001;49(7):3178–3186. - PubMed
    1. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 1997;350(9083):990–994. - PubMed
    1. Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H. Serum enterolactone and risk of breast cancer: a case-control study in Eastern Finland. Cancer Epidemiology Biomarkers and Prevention. 2001;10(4):339–344. - PubMed
    1. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet. 1999;354(9196):2112–2115. - PubMed
    1. Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H, Salonen JT. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio ischaemic heart disease risk factor study. Archives of Internal Medicine. 2003;163(9):1099–1104. - PubMed

LinkOut - more resources